Sort
48,018 grants matching “immunotherapy”
Interplay of inherent promiscuity and specificity in protein biochemical function with applications to drug discovery and exome analysis
$490,958Jeffrey Skolnick · Georgia Institute Of Technology · R35 · FY2024 · GM
Interplay of inherent promiscuity and specificity in protein biochemical function with applications to drug discovery and exome analysis
$490,958Jeffrey Skolnick · Georgia Institute Of Technology · R35 · FY2023 · GM
THERAPEUTIC MANUFACTURING
$490,937Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2013 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$490,853Benjamin W. Purow · University Of Virginia · R01 · FY2017 · CA
A New Paradigm to Prevent and Treat Micrometastases
$490,840Timothy P Cripe · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$490,839Chad A. Mirkin · Northwestern University · R01 · FY2024 · CA
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
$490,809Paul Michael Armistead · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Regulatory T cells in Autoimmune Disease
$490,772Charles Garrison Fathman · Yale University · U19 · FY2010 · AI
BCL11B activation as an approach for enhancing the efficacy of immunotherapy
$490,646Chintan Parekh · Beckman Research Institute/City Of Hope · R01 · FY2025 · AI
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$490,632Lingyin Li · Stanford University · R01 · FY2022 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$490,632Aaron F Straight · Stanford University · R01 · FY2023 · CA
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2024 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2023 · AI
Cellular mechanisms by which exhausted T cell responses are restored
$490,602Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2025 · AI
Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infection
$490,561Michael D Robek · Albany Medical College · R01 · FY2020 · AI
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$490,514Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2022 · CA
Co-targeting BET Bromodomain Proteins and MNK Kinases in Pancreatic Cancer
$490,514Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2025 · CA
COMBINING TROP2-DIRECTED CAR-NK CELLS WITH HIF2A INHIBITION FOR THE IMMUNOTHERAPY OF PANCREATIC CANCER
$490,500The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2025 · Defense Health Agency
Hexokinase 2 and cancer therapy
$490,487Nissim Hay · University Of Illinois At Chicago · R01 · FY2021 · CA
Developing whole-body computational phantoms for blood dosimetry to model the impact of radiation on the immune system
$490,465Harald Paganetti · Massachusetts General Hospital · R01 · FY2021 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$490,448Bryan Quilty Spring · Northeastern University · U01 · FY2024 · CA
Phase Changing Ultrasound Contrast Agents for Deep Tissue Imaging of Cellular Immunotherapies
$490,381Scott Hammond Medina · Pennsylvania State University, The · R01 · FY2024 · CA
Two Compartment Models to Improve Brain Tumor Therapy
$490,363Edward A Neuwelt · Oregon Health & Science University · R01 · FY2010 · CA
Research Training in Academic Medical Oncology
$490,275Richard E. Champlin · University Of Tx Md Anderson Can Ctr · T32 · FY2016 · CA
Renalase inhibition for treatment of unresectable melanoma
$490,257Harriet M Kluger · Yale University · R01 · FY2017 · CA